| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1980 | 2008 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.976 | 2 | 0 | 1992 | 2019 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.400 | None | 0.930 | 2 | 0 | 1993 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1994 | 2020 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.100 | None | 0.958 | 1 | 0 | 1994 | 2015 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1994 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.700 | None | 0.880 | 1 | 0 | 1994 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.100 | None | 0.917 | 2 | 0 | 1995 | 2015 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.950 | 8 | 0 | 1996 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.700 | strong | 0.962 | 2 | 0 | 1996 | 2020 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.400 | None | 0.750 | 2 | 0 | 1997 | 2019 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1997 | 2018 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 1997 | 2008 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 60 | 0 | 1998 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.080 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
heat shock protein family A (Hsp70) member 1B | 0.474 | 0.808 | 5.3E-03 |
|
disease | 0.050 | None | 0.800 | 4 | 0 | 1999 | 2007 | ||||||||
|
interleukin 18 | 0.365 | 0.923 | 3.1E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1999 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.929 | 1 | 0 | 1999 | 2019 | ||||||||
|
TNF receptor superfamily member 1B | 0.425 | 0.885 | 0.50 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2000 | 2019 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2000 | 2007 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
disease | 0.040 | None | 0.750 | 1 | 0 | 2000 | 2014 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.080 | None | 1.000 | 1 | 0 | 2000 | 2010 |